TC BioPharm (Holdings) plc
TC BioPharm (Holdings) plc (TCBWF): 6 pipeline candidates · 3 upcoming catalysts · 4 clinical trials. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
N/A
D/E 1.40 · 0% dilution
Lead: Phase 3
6 candidates
3 upcoming, next in ~12d
N/A
A transparent, data-derived signal for TC BioPharm (Holdings) plcacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
—
Cash
$1.2M
Quarterly Burn
—
Runway
—
Revenue
—
Cash Runway vs Catalysts
Upcoming catalyst timeline.
Pipeline (6 candidates)
| Drug | Phase |
|---|---|
| gb06 | Phase 3 |
| gb18 | Phase 1 |
| norditropinflexprotm | Phase 3 |
| peg-g-csf | Phase 3 |
| peg-g-csf injection (kexing biopharmaceutical co | Phase 3 |
| tcb008 | Phase 2 |
Upcoming Catalysts (3)
Clinical data readout — efficacy/safety results are a high-impact catalyst.
68.8% historical Phase 3 primary-endpoint success rate (n=362)
Clinical data readout — efficacy/safety results are a high-impact catalyst.
68.8% historical Phase 3 primary-endpoint success rate (n=362)
Frequently asked questions
How many drug candidates are in TC BioPharm (Holdings) plc's pipeline?
TC BioPharm (Holdings) plc (TCBWF) has 6 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is TC BioPharm (Holdings) plc's lead drug candidate?
TC BioPharm (Holdings) plc's most advanced tracked candidate is gb06 (Phase 3) for Growth Hormone Deficiency (GHD).
What is TC BioPharm (Holdings) plc's next catalyst?
TC BioPharm (Holdings) plc's next tracked catalyst is a Phase3_Topline event — "Phase 3 Topline: A Phase III Clinical Study of the Efficacy and Safety of Polyethylene Glycolized Human Granulocyte S" — expected June 30, 2026.
Who is the CEO of TC BioPharm (Holdings) plc?
Mr. Bryan Leland Kobel is the chief executive officer of TC BioPharm (Holdings) plc (TCBWF).
Get the full picture on TC BioPharm (Holdings) plc
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.